FdaApplication

NDA 213674

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTELLAS PHARMA US INC
application_typeNDA
approval_date2020-08-04

Products (2)

ProductActive ingredientStrengthDosage form
XTANDIENZALUTAMIDE40MGTABLET;ORAL
XTANDIENZALUTAMIDE80MGTABLET;ORAL

2 products